The TRDMT1–m5C axis discovered in this study extends the concept of DNA damage codes from post-translational modifications of proteins to post-transcriptional modifications of RNAs, providing exciting opportunities for targeted cancer therapy. This evidence concerns the gene TRDMT1 and cancer.